ERASCA INC. - COMMON STOCK

Erasca is Named One of Fierce Biotech’s “Fierce 15” Biotechnology Companies of 2021

27 9 2021 08:01:00 提供 Nasdaq GlobeNewswire

Erasca Announces First Patient Dosed in HERKULES-3, a Phase 1b/2 Gastrointestinal Cancer Master Protocol Evaluating ERAS-007 in Multiple Combinations

22 9 2021 08:00:00 提供 Nasdaq GlobeNewswire

Erasca Announces First Patient Dosed in HERKULES-2 Phase 1b/2 Lung Cancer Master Protocol Evaluating ERAS-007 in Multiple Combinations

09 9 2021 08:00:02 提供 Nasdaq GlobeNewswire

Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Encorafenib Combination

08 9 2021 08:00:02 提供 Nasdaq GlobeNewswire

Erasca Reports Second Quarter 2021 Financial Results and Business Updates

26 8 2021 16:01:00 提供 Nasdaq GlobeNewswire

Erasca Announces Pricing of Upsized Initial Public Offering

15 7 2021 21:58:28 提供 Nasdaq GlobeNewswire